| The Danish national patient register E Lynge, JL Sandegaard, M Rebolj Scandinavian journal of public health 39 (7_suppl), 30-33, 2011 | 3690 | 2011 |
| Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study J Dillner, M Rebolj, P Birembaut, KU Petry, A Szarewski, C Munk, ... Bmj 337, 2008 | 795 | 2008 |
| Cervical cancer screening policies and coverage in Europe A Anttila, L von Karsa, A Aasmaa, M Fender, J Patnick, M Rebolj, F Nicula, ... European Journal of Cancer 45 (15), 2649-2658, 2009 | 258 | 2009 |
| The challenges of organising cervical screening programmes in the 15 old member states of the European Union M Arbyn, M Rebolj, IMCM De Kok, M Fender, N Becker, M O’Reilly, ... European Journal of Cancer 45 (15), 2671-2678, 2009 | 219 | 2009 |
| Nonattendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands AB Bos, M Rebolj, JDF Habbema, M van Ballegooijen International journal of cancer 119 (10), 2372-2375, 2006 | 164 | 2006 |
| Primary cervical screening with high risk human papillomavirus testing: observational study M Rebolj, J Rimmer, K Denton, J Tidy, C Mathews, K Ellis, J Smith, ... bmj 364, 2019 | 152 | 2019 |
| Monitoring a national cancer prevention program: successful changes in cervical cancer screening in the Netherlands M Rebolj, M van Ballegooijen, LM Berkers, D Habbema International journal of cancer 120 (4), 806-812, 2007 | 140 | 2007 |
| Addition of ultrasound to mammography in the case of dense breast tissue: systematic review and meta-analysis M Rebolj, V Assi, A Brentnall, D Parmar, SW Duffy British journal of cancer 118 (12), 1559-1570, 2018 | 135 | 2018 |
| Condom use in prevention of Human Papillomavirus infections and cervical neoplasia: systematic review of longitudinal studies JUH Lam, M Rebolj, PA Dugue, J Bonde, M von Euler-Chelpin, E Lynge Journal of medical screening 21 (1), 38-50, 2014 | 127 | 2014 |
| Immunosuppression and risk of cervical cancer PA Dugué, M Rebolj, P Garred, E Lynge Expert review of anticancer therapy 13 (1), 29-42, 2013 | 127 | 2013 |
| Challenges to cervical cancer screening in a developing country: the case of Malaysia NH Othman, M Rebolj Asian Pac J Cancer Prev 10 (5), 747-751, 2009 | 84 | 2009 |
| Disagreement between human papillomavirus assays: an unexpected challenge for the choice of an assay in primary cervical screening M Rebolj, S Preisler, DM Ejegod, C Rygaard, E Lynge, J Bonde PLoS One 9 (1), e86835, 2014 | 79 | 2014 |
| Joint European Cohort Study. Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study J Dillner Bmj 337, 754, 2008 | 78 | 2008 |
| Risk of cervical cancer after completed post-treatment follow-up of cervical intraepithelial neoplasia: population based cohort study M Rebolj, T Helmerhorst, D Habbema, C Looman, R Boer, ... Bmj 345, 2012 | 76 | 2012 |
| Process performance of cervical screening programmes in Europe G Ronco, M van Ballegooijen, N Becker, A Chil, M Fender, P Giubilato, ... European Journal of Cancer 45 (15), 2659-2670, 2009 | 76 | 2009 |
| Cervical cancer screening at crossroads E Lynge, C Rygaard, MVP Baillet, PA Dugué, BB Sander, J Bonde, ... Apmis 122 (8), 667-673, 2014 | 70 | 2014 |
| Prevalence of human papillomavirus in 5,072 consecutive cervical SurePath samples evaluated with the Roche cobas HPV real-time PCR assay S Preisler, M Rebolj, A Untermann, DM Ejegod, E Lynge, C Rygaard, ... PloS one 8 (3), e59765, 2013 | 66 | 2013 |
| Risk of cervical cancer in women with autoimmune diseases, in relation with their use of immunosuppressants and screening: Population‐based cohort study PA Dugué, M Rebolj, J Hallas, P Garred, E Lynge International journal of cancer 136 (6), E711-E719, 2015 | 61 | 2015 |
| Recovery strategies following COVID-19 disruption to cervical cancer screening and their impact on excess diagnoses A Castanon, M Rebolj, F Pesola, P Sasieni British Journal of Cancer 124 (8), 1361-1365, 2021 | 59 | 2021 |
| Frequency of cervical intraepithelial neoplasia treatment in a well‐screened population SS Barken, M Rebolj, ES Andersen, E Lynge International journal of cancer 130 (10), 2438-2444, 2012 | 57 | 2012 |
